New potential antitumor quinazolinones derived from dynamic 2-undecyl benzoxazinone: Synthesis and cytotoxic evaluation
Hekal, Mohamed H.; Abu El-Azm, Fatma;
Abstract
Since the quinazoline and its derivatives have been considered as a novel class of cancer chemotherapeutic agents that show promising activity against different tumors, a new series of 6-iodo-2-undecylquinazolin-4(3H)-ones were prepared via reaction of 6-iodo-2-undecyl-4H-benzoxazin-4-one with nitrogen nucleophiles, namely, primary amines, 4-amino antipyrine, hydrazine hydrate, diamines, ethanol amine, and/or hydrazide derivatives and screened for their antitumor activity in vitro against a panel of three human tumor cell lines namely; hepatocellular carcinoma (liver) HepG2, colon cancer HCT-116, and mammary gland breast MCF-7. Compounds 14, 16, and 18 showed remarkable broad spectrum antitumor activity. All compounds were fully characterized by means of IR, MS, and 1H-NMR spectra.
Other data
| Title | New potential antitumor quinazolinones derived from dynamic 2-undecyl benzoxazinone: Synthesis and cytotoxic evaluation | Authors | Hekal, Mohamed H. ; Abu El-Azm, Fatma | Keywords | Cytotoxic evaluation;lauroyl chloride;quinazolinone;triazolo[4; 3-a]quinoline-4-carbonitrile;RAPID COLORIMETRIC ASSAY;BIOLOGICAL EVALUATION;ANTICANCER AGENTS;SCHIFF-BASES;DERIVATIVES;DESIGN;QUINAZOLIN-4(3H)-ONES;SULFONAMIDES;INHIBITORS;SURVIVAL | Issue Date | 2018 | Publisher | TAYLOR & FRANCIS INC | Journal | Synthetic Communications | Volume | 48 | Issue | 18 | Start page | 2391 | End page | 2402 | ISSN | 0039-7911 1532-2432 |
DOI | 10.1080/00397911.2018.1490433 | Scopus ID | 2-s2.0-85054842569 | Web of science ID | WOS:000449530700008 |
Attached Files
| File | Description | Size | Format | Existing users please Login |
|---|---|---|---|---|
| 3.pdf | 2.19 MB | Adobe PDF | Request a copy |
Similar Items from Core Recommender Database
Google ScholarTM
Check
Citations
27
in scopus
views
33
in Shams Scholar
downloads
11
in Shams Scholar
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.